CH Métropole Savoie
Chambéry, 73000, France
NCT Number: NCT04747405
Psychological impact of intensive care hospitalization for patients has been demonstrated during the last few years: anxiety, depression and post traumatic stress disorder. Hospitalizations during COVID-19 pandemic have been marked by factors such as confinement forbidding family members visits, stress on intensive care unit ...Those factors may have a psychological impact added to factors of long hospitalization and prolonged mechanical ventilation.
For all these reasons the investigators fear that patients hospitalized in intensive care during COVID-19 pandemic develop psychological trouble with an increased risk for those who experienced COVID-19 infection. The hypothesis therapy group added to standard care might have a positive impact on psychological troubles such as anxiety, depression and post traumatic stress disorder for patients who have been hospitalized in intensive care during COVID-19 pandemic.
The investigators will compare two groups:
* group receiving standard of care * group receiving standard of care and therapy group
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Chambéry, 73000, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
therapy group of maximum 8 people repeated twice
Time frame: 12 months after intensive care hospitalization
the aim is to compare the prevalence of post traumatic stress syndrome between both groups 12 months after exiting intensive care unit
Centre Hospitalier Metropole Savoie
Other
Acronym: GPR COVID
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03605407
Anxiety, Anxiety Disorders
Madrid, Spain
View Trial DetailsNCT06747793
Anxiety, Anxiety Disorders
Toulouse, France
View Trial DetailsNCT03264365
Anxiety Disorders, Behavior
Holbæk, Region Sjælland, Denmark
View Trial DetailsNCT01486121
Agnosia, Anxiety Disorders
Clermont-Ferrand, France
View Trial Details